2036-13-7 Usage
Uses
Used in Plant Growth Regulation:
6-Cyanopurine is used as a plant growth regulator for promoting cell division, growth, and development in plants. It stimulates cell proliferation, delays leaf senescence, and promotes the transition from vegetative to floral growth, which is essential for plant health and productivity.
Used in Tissue Culture:
6-Cyanopurine is used as a growth stimulant in tissue culture for stimulating bud formation and growth. It plays a crucial role in the successful propagation of plants through tissue culture techniques, ensuring the production of healthy and genetically uniform plantlets.
Used in Agricultural Applications:
6-Cyanopurine is used as a growth enhancer in agricultural applications for improving crop yield and quality. It helps in promoting the growth of plants, increasing the number of flowers and fruits, and ensuring a more uniform and robust growth.
Used in Plant Breeding:
6-Cyanopurine is used as a tool in plant breeding for inducing mutations and selecting desirable traits in plants. It can be used to create new plant varieties with improved characteristics, such as higher yield, better disease resistance, or enhanced nutritional content.
Used in Plant Biotechnology:
6-Cyanopurine is used as a component in plant biotechnology for genetic engineering and transformation studies. It can be used to study the effects of gene expression and regulation on plant growth and development, as well as to develop genetically modified plants with specific traits.
Used in Plant Health Management:
6-Cyanopurine is used as a stress mitigator in plant health management for enhancing the ability of plants to withstand various biotic and abiotic stresses. It can help in improving the overall health and resilience of plants, making them less susceptible to diseases and environmental challenges.
Check Digit Verification of cas no
The CAS Registry Mumber 2036-13-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,0,3 and 6 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 2036-13:
(6*2)+(5*0)+(4*3)+(3*6)+(2*1)+(1*3)=47
47 % 10 = 7
So 2036-13-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H3N5/c7-1-4-5-6(10-2-8-4)11-3-9-5/h2-3,5H
2036-13-7Relevant academic research and scientific papers
Hocek, Michal,Holy, Antonin
, p. 1386 - 1389 (1995)
A facile method of preparation of 6-cyanopurine bases from commercially available 6-chloropurines is reported.The 6-chloropurines were selectively protected by THP-functions and the protected derivatives reacted smoothly with tetraethylammonium cyanide and DABCO to give 6-cyanopurine derivatives that were easily deprotected to afford the title compounds.
A new approach to the synthesis of N,N-dialkyladenine derivatives
Alves, M. Jose,Carvalho, M. Alice,Carvalho, Silvia,Dias, Alice M.,Fernandes, Francisco H.,Proenca, M. Fernanda
, p. 4881 - 4887 (2008/03/14)
N,N-Dialkyladenine derivatives were prepared by two different reaction sequences starting from 5-amino-4-cyanoformimidoylimidazoles. When these imidazoles were treated with dimethylformamide diethyl acetal, a 5-aminomethyleneamino-4-cyanoformimidoylimidazole was isolated and evolved to the N,N-dialkyladenine in the presence of a secondary alkylamine. The same purine structure was isolated when the 5-amino-4-cyanoformimidoylimidazole was first treated with a secondary amine to give a stable 4-amidino-5- aminoimidazole. The desired product was generated when the 4-amidino-5- aminoimidazole was combined with dimethylformamide diethyl acetal, at room temperature. Wiley-VCH Verlag GmbH & Co. KGaA, 2007.
Process for preparing diaminopyrimido(4,5-d)pyrimidine glycoside and glycotide
-
, (2008/06/13)
The aminoglycoside and aminoglycotide N4 -(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)pyrimido[4,5-d]pyrimidine-4,8-diamine and N4 -(5-O-phosphono-β-D-ribofuranosyl-pyrimido[4,5-d]pyrimidine-4,8-diamine exhibit antiviral activity as well as cytotoxic activity against the L1210 and mammary 16/C tumor cell lines. An improved method for their production involves the production of a sylilated intermediate and reaction of the intermediate with tetra-O-acetyl-β-D-ribofuranose in the presence of the specific catalyst trimethylsilyltrifluoromethanesulfonate.
